Small molecule kinase inhibitors approved by the FDA from 2000 to 2011: a systematic review of preclinical ADME data
作者： Zhihong O'Brien , Mehran Fallah Moghaddam
DOI: 10.1517/17425255.2013.834046
关键词:
摘要: Introduction: Fourteen drugs targeting protein kinases have been approved by the United States Food and Drug Administration (FDA) between the years 2000 and 2011. While the …
informahealthcare.com参考文章(42)
Stam K, Groffen J, Heisterkamp N, Grosveld G, Hermans A, Bootsma D, De Klein A, The role of the Philadelphia translocation in chronic myelocytic leukemia. Annals of clinical research. ,vol. 18, pp. 278- ,(1986)
D. Fabbro, G. Fendrich, V. Guez, T. Meyer, P. Furet, J. Mestan, J. D. Griffin, P. W. Manley, S. W. Cowan-Jacob, Targeted Therapy with Imatinib: An Exception or a Rule? Inhibitors of Protein Kinases and Protein Phosphates. ,vol. 167, pp. 361- 389 ,(2005) , 10.1007/3-540-26670-4_13
Doriano Fabbro, Sandra W. Cowan-Jacob, Henrik Möbitz, Georg Martiny-Baron, Targeting cancer with small-molecular-weight kinase inhibitors. Methods of Molecular Biology. ,vol. 795, pp. 1- 34 ,(2012) , 10.1007/978-1-61779-337-0_1
P. C. Nowell, A minute chromosome in human chronic granulocytic leukemia Science. ,vol. 132, pp. 1497- ,(1960)
Peter Blume-Jensen, Tony Hunter, Oncogenic kinase signalling. Nature. ,vol. 411, pp. 355- 365 ,(2001) , 10.1038/35077225
A. V. Carrano, D. H. Moore, J. D. Rowley, B. H. Mayall, Quantification by DNA-based Cytophotometry of the 9q+/22q-Chromosomal Translocation Associated with Chronic Myelogenous Leukemia Cancer Research. ,vol. 37, pp. 3590- 3593 ,(1977)
G. GROSVELD, A. HERMANS, A. KLEIN, D. BOOTSMA, N. HEISTERKAMP, J. GROFFEN, The role of the Philadelphia translocation in chronic myelocytic leukemia. Annals of the New York Academy of Sciences. ,vol. 511, pp. 262- 269 ,(1987) , 10.1111/J.1749-6632.1987.TB36254.X
G. T. Rudkin, D. A. Hungerford, P. C. Nowell, DNA Contents of Chromosome Ph1 and Chromosome 21 in Human Chronic Granulocytic Leukemia Science. ,vol. 144, pp. 1229- 1232 ,(1964) , 10.1126/SCIENCE.144.3623.1229
Amrita V. Kamath, Jian Wang, Francis Y. Lee, Punit H. Marathe, Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL Cancer Chemotherapy and Pharmacology. ,vol. 61, pp. 365- 376 ,(2008) , 10.1007/S00280-007-0478-8
Kees Stam, Nora Heisterkamp, Gerard Grosveld, Annelies de Klein, Ram S. Verma, Morton Coleman, Harvey Dosik, John Groffen, Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. The New England Journal of Medicine. ,vol. 313, pp. 1429- 1433 ,(1985) , 10.1056/NEJM198512053132301